🇺🇸 FDA
Patent

US 9073918

Pyrazolo[4,3-b]pyridine-7-amine inhibitors of ALK5

granted A61PA61P35/00

Quick answer

US patent 9073918 (Pyrazolo[4,3-b]pyridine-7-amine inhibitors of ALK5) held by Takeda Pharmaceutical Company Limited expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P35/00